Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: LORD ERNIE who wrote (719)	12/1/1999 5:13:00 PM
From: GOLDFINGER	Read Replies (1) \| Respond to of 857

I do not know if the name Ascensio rings a bell, because he is actually the shorter... Sources are telling me that he needs about 30 trading days of normal volume to buy back his outstanding short position on HEB !!! But half of December there will be a Aids conference in the US where probably will be more positive news on Ampligen and its result on Aids. This could well be the last time we have seen the share price under 10 $ ! Regards, GF.